Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests steady strides program to prevent falls in seniors

NCT ID NCT07092176

Prevention Sponsor: Steady Strides: Fall Prevention and Stroke Rehabilitation Medical Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a structured fall prevention program called Steady Strides to standard primary care for adults aged 65 and older who have fallen at least twice in the past six months. The program includes medical check-ups, exercises, and education. Researchers will track how many falls participants have over six months to see if the program is more effective than usual care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Steady Strides fall prevention protocol (multifactorial intervention including medical assessment, exercise, and education)
What this could lead to
If successful, this could provide a more effective, structured fall prevention program for older adults, reducing injuries and hospital visits.
What could go wrong
This is a relatively small study (102 participants) and relies on self-reported falls, which may not be fully accurate. The intervention is complex and may not be easily scalable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 102 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

Jan 2029

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age: Participants must be community-dwelling older adults aged 65 years or older. Fall History: Participants must have reported experiencing at least two falls in the six months prior to the intake visit. Independence: Participants must report the ability to drive independently at the time of the intake visit and ambulate at least 10 feet with or without an assistive device (e.g. cane or walker, wheelchair ambulators are not included). Participants must report their ability to independently make medical decisions and sign their medical paperwork, including consent to participate in the study. Setting: Participants must reside in a community setting, not in a long-term care facility or hospital. Language: Participants must report ability to speak, read and comprehend English fluently. Exclusion Criteria: No additional exclusion criteria beyond those specified in the inclusion criteria. All individuals who meet the inclusion criteria are eligible to participate in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Fall prevention are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

flatfoot prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Fall prevention Falls

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Steady Strides

    RECRUITING

    Baltimore, Maryland, 21215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.